These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Mucopolysaccharidoses and the blood-brain barrier. Sahin O; Thompson HP; Goodman GW; Li J; Urayama A Fluids Barriers CNS; 2022 Sep; 19(1):76. PubMed ID: 36117162 [TBL] [Abstract][Full Text] [Related]
47. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis. Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853 [TBL] [Abstract][Full Text] [Related]
48. Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis-A Ten-Year Report from the China Children Transplant Group. Wang J; Luan Z; Jiang H; Fang J; Qin M; Lee V; Chen J Biol Blood Marrow Transplant; 2016 Nov; 22(11):2104-2108. PubMed ID: 27555533 [TBL] [Abstract][Full Text] [Related]
49. Abnormal polyamine metabolism is unique to the neuropathic forms of MPS: potential for biomarker development and insight into pathogenesis. Hinderer C; Katz N; Louboutin JP; Bell P; Tolar J; Orchard PJ; Lund TC; Nayal M; Weng L; Mesaros C; de Souza CFM; Dalla Corte A; Giugliani R; Wilson JM Hum Mol Genet; 2017 Oct; 26(19):3837-3849. PubMed ID: 28934395 [TBL] [Abstract][Full Text] [Related]
50. [Mucopolysaccharidosis: A review]. Michaud M; Belmatoug N; Catros F; Ancellin S; Touati G; Levade T; Gaches F Rev Med Interne; 2020 Mar; 41(3):180-188. PubMed ID: 31959364 [TBL] [Abstract][Full Text] [Related]
51. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Piotrowska E; Jakóbkiewicz-Banecka J; Barańska S; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G Eur J Hum Genet; 2006 Jul; 14(7):846-52. PubMed ID: 16670689 [TBL] [Abstract][Full Text] [Related]
52. Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches. Fraldi A; Serafini M; Sorrentino NC; Gentner B; Aiuti A; Bernardo ME Ital J Pediatr; 2018 Nov; 44(Suppl 2):130. PubMed ID: 30442177 [TBL] [Abstract][Full Text] [Related]
53. Animal models for mucopolysaccharidoses and their clinical relevance. Haskins M; Casal M; Ellinwood NM; Melniczek J; Mazrier H; Giger U Acta Paediatr Suppl; 2002; 91(439):88-97. PubMed ID: 12572849 [TBL] [Abstract][Full Text] [Related]
54. Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): a single dose of galsulfase further reduces urine glycosaminoglycans after hematopoietic stem cell transplantation. Whitley CB; Utz JR Mol Genet Metab; 2010 Dec; 101(4):346-8. PubMed ID: 20800524 [TBL] [Abstract][Full Text] [Related]
55. Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses. Fenzl CR; Teramoto K; Moshirfar M Clin Ophthalmol; 2015; 9():1633-44. PubMed ID: 26379420 [TBL] [Abstract][Full Text] [Related]
56. Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis. Ferrari S; Ponzin D; Ashworth JL; Fahnehjelm KT; Summers CG; Harmatz PR; Scarpa M Br J Ophthalmol; 2011 May; 95(5):613-9. PubMed ID: 20852315 [TBL] [Abstract][Full Text] [Related]
57. Craniovertebral junction pathological features and their management in the mucopolysaccharidoses. Sganzerla EP; Giussani C; Grimaldi M; Parini R; Ingelmo P; Trezza A; Visocchi M Adv Tech Stand Neurosurg; 2014; 40():313-31. PubMed ID: 24265052 [TBL] [Abstract][Full Text] [Related]
58. Perioperative complications in patients diagnosed with mucopolysaccharidosis and the impact of enzyme replacement therapy followed by hematopoietic stem cell transplantation at early age. Megens JH; de Wit M; van Hasselt PM; Boelens JJ; van der Werff DB; de Graaff JC Paediatr Anaesth; 2014 May; 24(5):521-7. PubMed ID: 24612129 [TBL] [Abstract][Full Text] [Related]
59. Mucopolysaccharidosis enzyme production by bone marrow and dental pulp derived human mesenchymal stem cells. Jackson M; Derrick Roberts A; Martin E; Rout-Pitt N; Gronthos S; Byers S Mol Genet Metab; 2015 Apr; 114(4):584-93. PubMed ID: 25748347 [TBL] [Abstract][Full Text] [Related]
60. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment. Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]